Avoro Capital Advisors LLC grew its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 11.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,300,000 shares of the biotechnology company’s stock after purchasing an additional 450,000 shares during the period. […]
Avoro Capital Advisors LLC lifted its position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 13.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,050,000 shares of the biotechnology company’s stock after purchasing an additional 1,500,000 shares during […]
Avoro Capital Advisors LLC lifted its position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 13.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,050,000 shares of the biotechnology company’s stock after purchasing an additional 1,500,000 shares during […]
Avoro Capital Advisors LLC acquired a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 4,444,444 shares of the exchange traded fund’s stock, valued at approximately $396,844,000. SPDR […]
Avoro Capital Advisors LLC acquired a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 4,444,444 shares of the exchange traded fund’s stock, valued at approximately $396,844,000. SPDR […]